Cargando…
RAGE Inhibitors in Neurodegenerative Diseases
Nonenzymatic reactions of reducing sugars with primary amino groups of amino acids, proteins, and nucleic acids, followed by oxidative degradations would lead to the formation of advanced glycation endproducts (AGEs). The AGEs exert multifactorial effects on cell damage leading to the onset of neuro...
Autores principales: | Reddy, V. Prakash, Aryal, Puspa, Soni, Pallavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136230/ https://www.ncbi.nlm.nih.gov/pubmed/37189749 http://dx.doi.org/10.3390/biomedicines11041131 |
Ejemplares similares
-
Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022) -
Polyphenols in Alzheimer’s Disease and in the Gut–Brain Axis
por: Reddy, V. Prakash, et al.
Publicado: (2020) -
Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
por: El-Far, Ali H., et al.
Publicado: (2020) -
Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors
por: Kim, Hyeon Jin, et al.
Publicado: (2021) -
RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review
por: Faruqui, Tabrez, et al.
Publicado: (2022)